Copyright
©The Author(s) 2023.
World J Hepatol. Dec 27, 2023; 15(12): 1307-1314
Published online Dec 27, 2023. doi: 10.4254/wjh.v15.i12.1307
Published online Dec 27, 2023. doi: 10.4254/wjh.v15.i12.1307
Table 1 Characteristics of samples used to study the variables and deaths 180 d after surgery, n (%)
All | Alive at 180 d | Death at 180 d | HR | P value | ||||
N | n = 429 | N | n = 409 | N | n = 20 | |||
Age, yr | 429 | 75.3 ± 4.1 | 409 | 75.3 ± 4.1 | 20 | 76.9 ± 4.9 | 1.52 (0.94-2.47) | 0.086 |
Male | 429 | 319 (74.4) | 409 | 306 (74.8) | 20 | 13 (65.0) | 0.61 (0.24-1.54) | 0.296 |
BMI | 429 | 26.9 ± 3.5 | 409 | 26.9 ± 3.6 | 20 | 26.9 ± 0.9 | 0.97 (0.52-1.82) | 0.921 |
ASA score | 429 | 2.60 ± 0.50 | 409 | 2.59 ± 0.50 | 20 | 2.90 ± 0.31 | 4.49 (1.47-13.74) | 0.008 |
Comorbidity > 2 | 429 | 142 (33.1) | 409 | 129 (31.5) | 20 | 13 (65.0) | 3.92 (1.56-9.82) | 0.004 |
HBV | 429 | 80 (18.6) | 409 | 80 (19.6) | 20 | 0 (0.0) | - | - |
HCV | 429 | 217 (50.6) | 409 | 210 (51.3) | 20 | 7 (35.0) | 0.51 (0.2-1.28) | 0.151 |
ALD | 429 | 60 (14.0) | 409 | 56 (13.7) | 20 | 4 (20.0) | 1.58 (0.53-4.72) | 0.415 |
Others | 429 | 72 (16.8) | 409 | 63 (15.4) | 20 | 9 (45.0) | 4.3 (1.78-10.37) | 0.001 |
F4 cirrhosis | 429 | 178 (41.5) | 409 | 173 (42.3) | 20 | 5 (25.0) | 0.46 (0.17-1.27) | 0.134 |
CHILD A | 429 | 370 (86.2) | 409 | 353 (86.3) | 20 | 17 (85.0) | 0.92 (0.27-3.13) | 0.891 |
MELD score | 429 | 7.4 ± 2.1 | 409 | 7.4 ± 2.0 | 20 | 8.9 ± 2.7 | 1.25 (1.09-1.44) | 0.001 |
Albumin | 382 | 3.80 ± 0.60 | 367 | 3.80 ± 0.60 | 15 | 3.71 ± 0.77 | 0.75 (0.33-1.73) | 0.504 |
Bilirubin | 424 | 1.05 ± 0.64 | 404 | 1.05 ± 0.64 | 20 | 0.99 ± 0.54 | 0.81 (0.37-1.76) | 0.587 |
Creatinin | 425 | 1.03 ± 0.36 | 405 | 1.02 ± 0.36 | 20 | 1.17 ± 0.42 | 2.55 (0.9-7.2) | 0.077 |
INR | 422 | 1.20 ± 0.23 | 402 | 1.20 ± 0.23 | 20 | 1.17 ± 0.28 | 0.51 (0.07-3.8) | 0.508 |
AST | 424 | 68 ± 61 | 405 | 69 ± 61 | 19 | 48 ± 41 | 0.92 (0.85-1) | 0.045 |
ALT | 201 | 51 ± 80 | 182 | 52 ± 82 | 19 | 41 ± 48 | 0.98 (0.91-1.05) | 0.540 |
GGT | 192 | 145 ± 218 | 174 | 145 ± 218 | 18 | 146 ± 228 | 1 (0.98-1.02) | 0.958 |
Platelets | 425 | 191 ± 92 | 406 | 191 ± 92 | 19 | 177 ± 85 | 0.98 (0.93-1.04) | 0.509 |
Number of lesions | 429 | 1.09 ± 0.30 | 409 | 1.09 ± 0.31 | 20 | 1.05 ± 0.22 | 0.54 (0.08-3.77) | 0.531 |
Size of biggest lesion (mm) | 429 | 33 ± 10 | 409 | 32 ± 10 | 20 | 37 ± 13 | 1.26 (1.01-1.58) | 0.043 |
Bilobar lesion | 429 | 8 (1.9) | 409 | 8 (2.0) | 20 | 0 (0.0) | - | - |
Preop treatment | 429 | 53 (12.4) | 409 | 50 (12.2) | 20 | 3 (15.0) | 1.24 (0.36-4.23) | 0.732 |
Major HTC | 429 | 56 (13.1) | 409 | 55 (13.4) | 20 | 1 (5.0) | 0.34 (0.05-2.56) | 0.297 |
- Citation: Conticchio M, Inchingolo R, Delvecchio A, Ratti F, Gelli M, Anelli MF, Laurent A, Vitali GC, Magistri P, Assirati G, Felli E, Wakabayashi T, Pessaux P, Piardi T, di Benedetto F, de'Angelis N, Briceño J, Rampoldi A, Adam R, Cherqui D, Aldrighetti LA, Memeo R. Peri-operative score for elderly patients with resectable hepatocellular carcinoma. World J Hepatol 2023; 15(12): 1307-1314
- URL: https://www.wjgnet.com/1948-5182/full/v15/i12/1307.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i12.1307